MMSL 2011, 80(1):12-20 | DOI: 10.31482/mmsl.2011.002

A COMPARISON OF THE NEUROPROTECTIVE EFFICACY OF INDIVIDUAL OXIMES (HI-6, TRIMEDOXIME, K203) AND THEIR MIXTURES (HI-6 + TRIMEDOXIME, HI-6 + K203) IN CYCLOSARIN-POISONED RATSOriginal article

Jiří Kassa ORCID...1*, Jana ®ďárová Karasová ORCID...2
1 Department of Toxicology, Faculty of Military Health Sciences, Hradec Králové, Czech Republic
2 Department of Public Health, Faculty of Military Health Sciences, Hradec Králové, Czech Republic

The ability of three oximes (HI-6, trimedoxime, K203) to reduce cyclosarin-induced acute neurotoxic signs and symptoms was compared with the neuroprotective efficacy of two combinations of oximes (HI-6 + trimedoxime, HI-6 + K203) using a functional observational battery. Cyclosarin-induced neurotoxicity and the neuroprotective effects of HI-6, trimedoxime or K203 alone and HI-6 combined with trimedoxime or K203 in rats poisoned with cyclosarin at a sublethal dose (80 μg/kg i.m.; 70% of LD50 value) were monitored by the functional observational battery at 24 hours and 7 days following cyclosarin challenge. The results indicate that all types of antidotal treatment are able to survive cyclosarin-poisoned rats 7 days following cyclosarin poisoning while one non-treated cyclosarin-poisoned rats died within 24 hours following cyclosarin challenge. All three oximes alone as well as both oxime mixtures combined with atropine were able to slightly decrease cyclosarin-induced neurotoxicity in the case of sublethal poisoning but they did not eliminate all cyclosarin-induced acute neurotoxic signs and symptoms. Their ability to reduce cyclosarin-induced acute neurotoxicity was almost the same regardless of type of antidotal treatment. Thus, the tested combinations of oximes were not able to increase the neuroprotective effectiveness of antidotal treatment of acute cyclosarin poisoning compared to the individual oximes.

Keywords: cyclosarin; functional observational battery; neurotoxicity; mixture of oximes; rats

Received: January 22, 2011; Revised: March 9, 2011; Published: April 6, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kassa, J., & ®ďárová Karasová, J. (2011). A COMPARISON OF THE NEUROPROTECTIVE EFFICACY OF INDIVIDUAL OXIMES (HI-6, TRIMEDOXIME, K203) AND THEIR MIXTURES (HI-6 + TRIMEDOXIME, HI-6 + K203) IN CYCLOSARIN-POISONED RATS. MMSL80(1), 12-20. doi: 10.31482/mmsl.2011.002
Download citation

References

  1. BAJGAR, J. Organophosphate/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem., 2004, vol. 38, p. 151-216. Go to original source... Go to PubMed...
  2. BAJGAR, J. Complex view on poisoning with nerve agents and organophosphates. Acta Med. (Hradec Kralove), 2005, vol. 48, 3-21. Go to original source...
  3. CASSEL, G. - KARLSSON, L. - WAARA, L., et al. Pharmacokinetics and effects of HI-6 in blood and brain of soman-intoxicated rats: a microdialysis study. Eur. J. Pharmacol., 1997, vol. 332, p. 43-52. Go to original source... Go to PubMed...
  4. CLEMENT, J.G. - SHILOFF, J.D. - GENNINGS, C. Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime, against tabun and soman poisoning of mice. Arch. Toxicol., 1987, vol. 61, p. 70-75. Go to original source... Go to PubMed...
  5. FRANTIK, E. - HORNYCHOVA, M. Clustering of neurobehavioral measures of toxicity. Homeostasis, 1995, vol. 36, p. 19-25.
  6. JOKANOVIC, M. - PROSTRAN, M. Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr. Med. Chem., 2009, vol. 16, p. 2177-2188. Go to original source... Go to PubMed...
  7. KALASZ, H. - LAUFER, R. - SZEGI, P., et al. HPLC study of the pharmacokinetics of K-203. Acta Chromatogr., 2008, vol. 20, p. 575-584. Go to original source...
  8. KALASZ, H. - FÜRESZ, J. - TEKES, K. Monitoring the pharmacokinetics of pyridinium aldoximes in the body. Mini-Rev. Med. Chem., 2009, vol. 9, p. 448-462. Go to original source... Go to PubMed...
  9. KASSA, J. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J. Toxicol. Clin. Toxicol., 2002, vol. 40, p. 803-816. Go to original source... Go to PubMed...
  10. KASSA, J. - CABAL, J. A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol. Toxicol., 1999, vol. 84, p. 41-45. Go to original source... Go to PubMed...
  11. KASSA, J. - KARASOVA, J. - MUSILEK, K., et al. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Toxicology, 2008, vol. 243, p. 311-316. Go to original source... Go to PubMed...
  12. KASSA, J. - KARASOVA, J. - VASINA, L., et al. A comparison of neuroprotective efficacy of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in tabun-poisoned rats. Drug Chem. Toxicol., 2009, vol. 32, p. 128-138. Go to original source... Go to PubMed...
  13. KASSA, J. - KUCA, K. - BARTOSOVA L., et al. The development of new structural analogues of oximes for the antidotal treatment of poisoning by nerve agents and the comparison of their reactivating and therapeutic efficacy with currently available oximes. Curr. Org. Chem., 2007, vol. 11, p. 267-283. Go to original source...
  14. KASSA, J. - ZDAROVA KARASOVA, J. - CAISBERGER F., et al. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats nad mice. Toxicol. Mech. Meth., 2009, vol. 19, p. 547-551. Go to original source... Go to PubMed...
  15. KASSA, J. - ZDAROVA KARASOVA, J. - MUSILEK, K., et al. A comparison of reactivating and therapeutic efficacy of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats nad mice. Toxicol. Mech. Meth., 2009, vol. 19, p. 346-350. Go to original source... Go to PubMed...
  16. KASSA, J. - ZDAROVA KARASOVA, J. - TESAROVA, S., et al. A comparison of the neuroprotective efficacy of newly developed oximes (K156, K203) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats. Acta Med. (Hradec Kralove), 2008, vol. 51, p. 215-221. Go to original source...
  17. KOVACEVIC, V. - MAKSIMOVIC, M. - DELJAC, V., et al. Protective effects of mixture of oximes in poisoning by nerve chemical warfare agents. Acta Pharm. Jugoslav., 1991, vol. 41, p. 75-78.
  18. KOVACEVIC, V. - MAKSIMOVIC, M. - PANTELIC, D., et al. Protective and reactivating effects of HI-6 PAM-2 mixture in rats poisoned with nerve chemical warfare agents. Acta Pharm. Jugoslav., 1989, vol. 39, p. 161-165.
  19. KOVARIK, Z. - LUCIC VRDOLJAK, A. - BEREND, S., et al. Evaluation of oxime K203 as antidote in tabun poisoning. Arh. Hig. Rada Toksikol., 2009, vol. 60, p. 19-26. Go to original source... Go to PubMed...
  20. KUCA, K. - CABAL, J. - JUN D., et al. Potency of new structurally different oximes to reactivate cyclosarin-inhibited human brain acetylcholinesterase. J. Enz. Inhib. Med. Chem., 2006, vol. 21, p. 663-666. Go to original source... Go to PubMed...
  21. KUCA, K. - CABAL, J. - JUN, D., et al. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions. J. Appl. Toxicol., 2005, vol. 25, p. 296-300. Go to original source... Go to PubMed...
  22. LORKE, DE. - KALASZ, H. - PETROIANU, GA., et al. Entry of oximes into the brain: A review. Curr. Med. Chem., 2008, vol. 15, p. 743-753. Go to original source... Go to PubMed...
  23. LOTTI, M. Organophosphorus compounds. In SPENCER, PS. - SCHAUMBURG, HH. (eds). Experimental and Clinical Neurotoxicology, New York, Oxford University Press, 2000, p. 898-925.
  24. LUNDY, PM. - RAVEH, L. - AMITAI, G. Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning. Toxicol. Rev., 2006, vol. 25, p. 231-243. Go to original source... Go to PubMed...
  25. MAKSIMOVIC, M. - KOVACEVIC, V. Protective and reactivating effects of HI-6-toxogonin mixture in rats and guinea-pigs poisoned by nerve agents. Acta Pharm. Jugoslav., 1989, vol. 39, p. 27-33.
  26. MARRS, TC. Organophosphate poisoning. Pharmacol. Ther., 1993, vol. 58, p. 51-66. Go to original source... Go to PubMed...
  27. MARRS, TC. - RICE, P. - VALE, JA. The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol. Rev. 2006, vol. 25, p. 297-323. Go to original source... Go to PubMed...
  28. MAXWELL, DM. - KOPLOVITZ, I. - WOREK, F., et al. A structure-activity analysis of the variation in oxime efficacy against nerve agents. Toxicol. Appl. Pharmacol., 2008, vol. 231, p. 157-164. Go to original source... Go to PubMed...
  29. MCDONOUGH, JH. JR. - SHIH, T-M. Neuropharmacological modulation of nerve agent-induced seizure and neuropathology. Neurosci Biobehav. Rev., 1997, vol. 21, p. 559-579. Go to original source... Go to PubMed...
  30. MUSILEK, K. - JUN, D. - CABAL, J., et al. Design of a potent reactivator of tabun-inhibited acetylcholinesterase - synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203). J. Med. Chem., 2007, vol. 50, p. 5514-5518. Go to original source... Go to PubMed...
  31. MUSILEK, K. - KUCA, K. - JUN, D., et al. Synthesis of bispyridinium compounds bearing propane linker and evaluation of their reactivation activity against tabun- and paraoxon-inhibited acetylcholinesterase. Lett. Org. Chem., 2006, vol. 3, p. 831-835. Go to original source...
  32. MUSILEK, K. - KUCA, K. - JUN, D., et al. Progress in synthesis of new acetylcholinesterase reactivators in period 1990-2004. Curr. Org. Chem., 2007, vol. 11, p. 229-238. Go to original source...
  33. ROTH, Z. - JOSIFKO, M. - MALY, V., et al. Statistical Methods in Experimental Medicine (in Czech), SZN Praha 1962. Go to PubMed...
  34. SAKURADA, K. - MATSUBARA, K. - SHIMIZU, K., et al. Pralidoxime iodide (2-PAM) penetrates across the blood-brain barrier. Neurochem. Res., 2003, vol. 28, p. 1401-1407. Go to original source... Go to PubMed...
  35. SHROT, S. - MARKEL, G. - DUSHNITSKY, T., et al. The possible use of oximes as antidotal therapy in organophosphate-induced brain damage. NeuroToxicology, 2009, vol. 30, p. 167-173. Go to original source... Go to PubMed...
  36. TAYLOR, P. Anticholinesterase agents. In HARDMAN, JG. - LIMBIRD, LE. (eds). The Pharmacological Basis of Therapeutics. New York, McGraw Hill, 1996, p.161-176.
  37. VOICU, VA. - THIERMANN, H. - RÄDULESCU, FS., et al. The toxicokinetics and toxicodynamics of organophosphonates versus the pharmacokinetics and pharmacodynamics of oxime antidotes: biological consequences. Bas. Clin. Pharmacol. Toxicol. 2010, vol. 106, p. 73-85. Go to original source... Go to PubMed...
  38. WOREK, F. - AURBEK, N. - THIERMANN, H. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro. J. Appl. Toxicol., 2007, vol. 27, p. 582-588. Go to original source... Go to PubMed...
  39. WOREK, F. - DIEPOLD, C. - EYER, P. Dimethylphosphoryl-inhibited human cholinesterases: inhibition, reactivation, and aging kinetics. Arch. Toxicol., 1999, vol. 73, p. 7-14. Go to original source... Go to PubMed...